31St May-6Th June Weekly Compilation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
0 January to July 2021
0 www.journalsofindia.com January to July 2021 SCIENCE & TECH ............................................................................................................................................................... 6 1. REUSABLE LAUNCH VEHICLE TECHNOLOGY DEMONSTRATION PROGRAMME(RLV-TD) ................................................. 6 2. GAGANYAAN MISSION ..................................................................................................................................................... 6 3. MARS ORBITER MISSION (MOM) ..................................................................................................................................... 6 4. CHANDRAYAAN MISSION................................................................................................................................................. 7 5. SOLAR MISSION ............................................................................................................................................................... 8 6. ARTEMIS ACCORD ............................................................................................................................................................ 9 7. NATIONAL MISSION ON INTERDISCIPLINARY CYBER-PHYSICAL SYSTEM (NMICPS) ....................................................... 10 8. SMART ANTI-AIRFIELD WEAPON (SAAW) ...................................................................................................................... 10 9. AQUAPONICS ................................................................................................................................................................ -
News in Focus ISHANT CHAUHAN/AP/SHUTTERSTOCK ISHANT People Queue to Refill Oxygen Cylinders for Overwhelmed Medical Facilities in New Delhi
The world this week News in focus ISHANT CHAUHAN/AP/SHUTTERSTOCK ISHANT People queue to refill oxygen cylinders for overwhelmed medical facilities in New Delhi. CORONAVIRUS VARIANTS ARE SPREADING IN INDIA — WHAT SCIENTISTS KNOW SO FAR Variants including B.1.617 have been linked to India’s surge in infections. Researchers are hurrying to determine how much of a threat they pose. By Gayathri Vaidyanathan detected in India might be more transmissible variants were behind a series of surges in India. and slightly better at evading immunity than Genomic data indicated that B.1.1.7, first iden- cientists are working to understand existing variants. Animal models also hint that tified in the United Kingdom, was dominant in several coronavirus variants now it might be able to cause more severe disease. Delhi and the state of Punjab, and a new variant circulating in India, where a ferocious Researchers want to know whether this variant dubbed B.1.618 was present in West Bengal. second wave of COVID-19 has devas- and others might be driving the second wave B.1.617 was dominant in Maharashtra. tated the nation and caught authori- and what kind of danger they pose globally. But, since then, B.1.617 has overtaken B.1.618 Sties unawares. The country recorded nearly In just a few weeks, the B.1.617 variant has in West Bengal, has become the leading vari- 400,000 new infections on 9 May, taking its become the dominant strain across India and ant in many states, and is increasing rapidly total to more than 22 million (see ‘Surging has spread to about 40 nations, including the in Delhi. -
In 2020, India Dealt with the First Wave of COVID-19 Pandemic With
PREFACE n 2020, India dealt with the first wave of COVID-19 pandemic with collective measures, Iscientific approach, and awareness. Undoubtedly the second wave of the pandemic is testing our patience and the extent to which we can all tolerate its fangs. The impact of the second wave has seen shortage of medical oxygen across the nation. But, the intelligent use of technology and well-planned resource allocation to tackle the new wave of the pandemic has been dealt with at a war-footing. The current edition, COVID 2021: Nation’s S&T Efforts Against COVID-19, has been compiled to inform our readers and strengthen the usefulness of any published information. This edition contains compilation and coverage of information related to the capacity enhancement of medical oxygen, start-up spotlights, research contributions, and so on. To bridge the gap among scientific contributions, leadership and administrative efforts, and the perspective of the general public, Vigyan Prasar is continuously reaching out to its audiences in the shape of a regular e-newsletter, taking its mandate of science communication, popularisation and extension to the next level. Our effort is firmly based on the fact that “Science gathers knowledge faster than society gathers wisdom”. The steady increase in the number of recoveries and the significant and continuous decrease in positivity rate provide us the much-needed assurance that this may be the outcome of improving the health infrastructure and making health the cornerstone at the policy level. We wish an engaging reading to our audiences across all strata of the society and look forward to suggestions and feedback at [email protected]. -
White Paper on the Management of COVID-19 by the Government of India
White Paper on the Management of COVID-19 by the Government of India JUNE 2021 TABLE OF CONTENTS 1. Executive Summary…………………………………………... (i) 2. The Need for a White Paper on the Management of the COVID-19 Pandemic………………………………….. 1 3. Early Inaction Against COVID-19………………………….. 5 4. Policy Response to the First Wave………………………… 10 5. Hubris and Political Avarice………………………………… 18 6. Ignoring the Signs and the Science………………………... 27 7. Unforgivable Negligence…………………………..…………. 41 8. Vaccine Mismanagement..……………………………...…… 51 9. Wider Impact of Policy Failures…………………………….. 82 10. The Way Ahead……………………………………………….. 89 11. Annexure 1. Indian National Congress: Compendium of Statements, Letters and Resolutions on COVID-19 (March 2020 - June 2021)…………………………………… A1 Executive Summary The mismanagement of the COVID-19 pandemic has been independent India’s gravest governance failure. The Union government under Prime Minister Narendra Modi did not take adequate measures to prevent and contain the pandemic. Therefore, there is a Need for a White Paper (Chapter-1) that examines the government’s acts of omission and commission, its impact on India and suggests constructive measures to improve policy responses to the current and future waves of the pandemic. The Modi government’s handling of the COVID-19 crisis began with its Early Inaction in January 2020 (detailed in Chapter-2). The government ignored early warnings from experts and political leaders from the Opposition. It failed to learn from the lessons and response models of other countries which had been hit by the pandemic. It did not scale up nationwide the lessons from Kerala’s experience in successfully suppressing a virus outbreak (the Nipah virus). -
Asia COVID-19 & Vaccine Tracker
9 July 2021 Free to View Asia COVID-19 & Vaccine Tracker Economics - Asia Tougher restrictions As COVID-19 cases continue to surge across Asia, more Yun Liu authorities have re-imposed restrictions or even lockdowns Economist The Hongkong and Shanghai Banking Corporation Limited But this has increased the urgency to ramp up vaccine Frederic Neumann procurement and roll-out in the region Co-Head of Asian Economics Research The Hongkong and Shanghai Banking Corporation Limited Some economies have started pilot programmes to revive tourism, but a full re-opening may take a long time Maitreyi Das Associate Bangalore Déjà vu No end in sight just yet. The Delta variant is causing daily new COVID-19 cases to surge to new record highs across Asia, prompting more governments to re-impose tougher restrictions. This is particularly evident in ASEAN, where cases in Indonesia and Vietnam have been rising sharply. The former has extended its tightening measures throughout the country until 20 July, while the latter will impose a strict lockdown in Ho Chi Minh City (HCMC) from 9 July for 15 days. Meanwhile, just two weeks before the Tokyo Olympics, Japan is set to declare its fourth state of emergency in Tokyo from 12 July to 20 August, raising the possibility of no spectators attending the games. Meanwhile, Singapore is the only country that has decided to ease its social restrictions from 12 July, as new cases remain low. Urgency on vaccination The recent outbreaks in the region has alerted the authorities that the key to exiting the pandemic is to accelerate vaccine procurement and roll-out. -
The-Recitals-January-2021-Vajiram.Pdf
INDEX Message From The Desk Of Director 1 1. Feature Article 2-7 a. Future Of Food b. Vaccine Maitri Initiative 2. Mains Q&A 12-25 3. Prelims Q&A 26-67 4. Bridging Gaps 68-123 1. Vertical and Horizontal Reservations 2. Plea To Bar Disqualified Lawmakers From Contesting Bye-Polls To Same House 3. The India Justice Report 2020 4. Adultery Law And The Armed Forces 5. Urban Local Bodies (ULB) Reforms 6. PRAGATI Meeting 7. Toycathon 8. Henley Passport Index 9. GAVI Board 10. National Girl Child Day 11. Satyameva Jayate Programme 12. Smart Classes For Rural Schools VAJIRAM AND RAVI The Recitals (January 2021) 13. Special Marriage Act 14. Freight Portal 15. Agri-Hackathon 2020 16. Investment Trends Monitor 17. Bad Banks 18. Scheme For Ethanol Distillation 19. Trade Deficit With China 20. Pradhan Mantri Kaushal Vikas Yojana 3.0 21. Regulatory Structure For NBFCs 22. Startup India Seed Fund 23. Kala Utsav 2020 24. Oldest Cave Art 25. Jallikattu 26. Gulf Leaders Sign Solidarity and Stability Deal 27. Russia Withdraws from Open Skies Treaty 28. Scottish Independence Referendum 29. China Holds Third South Asia Multilateral Meet 30. US President Donald Trump Impeached 31. US Eases Restrictions on Contact with Taiwan 32. New START Treaty 33. UAE’s New Citizenship Policy 34. Article 19 of UN Charter 35. H-1B Visas and New Wage-based Rules 36. India at the UN High Table 37. India - UK Cooperation Against Cross-Border Terrorism 38. India-France to Expand Ecological Partnership 39. Document on the U.S. Strategic Framework for the Indo-Pacific 40. -
En Este Número
Boletín Científico No. 18 (1-10 julio/2021) EN ESTE NÚMERO VacCiencia es una publicación dirigida a Resumen de candidatos vacu- investigadores y especialistas dedicados a nales contra la COVID-19 ba- la vacunología y temas afines, con el ob- sadas en la plataforma de sub- jetivo de serle útil. Usted puede realizar unidad proteica en desarrollo a sugerencias sobre los contenidos y de es- nivel mundial. (segunda parte) ta forma crear una retroalimentación Artículos científicos más que nos permita acercarnos más a sus recientes de Medline sobre necesidades de información. vacunas. Patentes más recientes en Patentscope sobre vacunas. Patentes más recientes en USPTO sobre vacunas. 1| Copyright © 2020. Todos los derechos reservados | INSTITUTO FINLAY DE VACUNAS Resumen de vacunas contra la COVID-19 basadas en la plataforma de subunidad proteica en desarrollo a nivel mundial (segunda parte) Las vacunas de subunidades antigénicas son aquellas en las que solamente se utilizan los fragmentos específicos (llamados «subunidades antigénicas») del virus o la bacteria que es indispensable que el sistema inmunitario reconozca. Las subunidades antigénicas suelen ser proteínas o hidratos de carbono. La mayoría de las vacunas que figuran en los calendarios de vacunación infantil son de este tipo y protegen a las personas de enfermedades como la tos ferina, el tétanos, la difteria y la meningitis meningocócica. Este tipo de vacunas solo incluye las partes del microorganismo que mejor estimulan al sistema inmunitario. En el caso de las desarrolladas contra la COVID-19 contienen generalmente, la proteína S o fragmentos de la misma como el Dominio de Unión al Receptor (RBD, por sus siglas en inglés). -
INTERNATIONAL STUDENT COVID VACCINE LIST and COMMUNICATION Dear International Student
INTERNATIONAL STUDENT COVID VACCINE LIST and COMMUNICATION Dear International Student We have provided a list of Selected Countries to help you find the COVID-19 vaccine you may have already received. Please see the “WHO” list below to find your COVID-19 vaccine, and if it has been APPROVED. And please upload your record following these directions: https://youtu.be/wvBGeRqIMHc If you see that your vaccine HAS NOT yet been approved by “WHO”, you may be required to receive an approved COVID-19 vaccine and upload those records to meet UC campus policy and requirements. Many US Airports are now providing COVID-19 vaccine on-site. Here is a list of several California Airports that you may arriving where you may receive a vaccine IMMEDIATELY upon your entry into the U.S. LAX – Los Angeles https://www.flylax.com/TravelSafely SNA – Orange County https://hoagurgentcare.com/airport/ SFO – San Francisco https://www.flysfo.com/travel-well/vaccination-site-sfo If you have any additional questions or concerns, please call (949)824-2300 for support. THANK YOU for helping to ensure UCI continues to be a SAFE and HEALTHY Campus! Dr Chang INDIA SOUTH KOREA TAIWAN INDONESIA VIETNAM JAPAN Vaccine Vaccine Vaccine Vaccine Vaccine Vaccine Oxford–AstraZeneca Oxford-AstraZeneca Sinovac Sputnik V Pfizer–BioNTech Covishield Pfizer–BioNTech Oxford–AstraZeneca Oxford–AstraZeneca Sinopharm Janssen Sinopharm Moderna Pfizer–BioNTech Moderna Pfizer–BioNTech Moderna Moderna Covaxin Novavax Moderna Johnson & Johnson Oxford–AstraZeneca Sputnik V Novavax Nanocovax Johnson & Johnson Sputnik V COVIVAC Sputnik V CanSino Vabiotech MVC-COV1901 ZyCoV-D Corbevax Covovax . -
Important Definitions (06-12Jun21)
IMPORTANT DEFINITIONS (06-12JUN21) 1. Juvenile Justice (Care and Protection of Children) Act, 2015 (noun) – An Act to consolidate and amend the law relating to children alleged and found to be in conflict with law and children in need of care and protection by catering to their basic needs through proper care, protection, development, treatment, social re-integration, by adopting a child-friendly approach in the adjudication and disposal of matters in the best interest of children and for their rehabilitation through processes provided, and institutions and bodies established, hereinunder and for matters connected therewith or incidental thereto. 2. Central Adoption Resource Authority (CARA) (noun) – a statutory body of Ministry of Women & Child Development, Government of India. It functions as the nodal body for adoption of Indian children and is mandated to monitor and regulate in-country and inter-country adoptions. CARA is designated as the Central Authority to deal with inter-country adoptions in accordance with the provisions of the Hague Convention on Inter-country Adoption, 1993, ratified by Government of India in 2003. CARA primarily deals with adoption of orphan, abandoned and surrendered children through its associated /recognised adoption agencies. 3. National Commission for Protection of Child Rights (NCPCR) (noun) – it is a statutory body under the Commissions for Protection of Child Rights (CPCR) Act, 2005 under the administrative control of the Ministry of Women & Child Development, Government of India. The Commission’s Mandate is to ensure that all Laws, Policies, Programmes, and Administrative Mechanisms are in consonance with the Child Rights perspective as enshrined in the Constitution of India and also the UN Convention on the Rights of the Child. -
CME INDIA COVID-19 Vaccination Protocol 2021 July Updat
COVID-19 VACCINATION PROTOCOL JULY 21 CME INDIA CME 1 CME INDIA CME INDIA COVID-19 Vaccination Protocol First published: 29th April 2021. Last Updated: 6th July 2021. With the rapid rise in Covid-19 cases in INDIA, CME INDIA has now compiled its own vaccination protocol with inputs from key medical experts. The goal of this document is to help the medical community in managing the current Covid-19 situation and provide insight into the COVID-19 Vaccination Program in India. This document will be updated from time to time, so please check www.cmeindia.in and CME INDIA Downloads section regularly. Alternatively, you can choose to navigate to the various key sections of CME INDIA: Explore CME INDIA Repository Examine CME INDIA Case Study Read History Today in Medicine Register for Future CMEs View CME INDIA Downloads 2 CME INDIA 3 CME INDIA Basic Framework By: Dr. Akash Singh, MD (Med) MSc (Diabetes) Consultant Physician and Diabetologist Spandan Multi Speciality Hospital, Vadodara. Dr. S. K. Gupta, MD (Med), FICP, CFM(France) Clinical Asst. Professor GS Medical College, CCSU, Uttar Pradesh India. Visiting Consultant, Max Super Specialty Hospital, New Delhi. Dr. Kiran Shah, Consultant Physician MBBS, MD, Spandan Multi Speciality Hospital Vadodara. Edited By: Dr. N.K. Singh, MD, FICP, Diabetologist Physician, Dhanbad, Editor - cmeindia.in. Advisor and Reviewer: Dr. Awadhesh Kumar Singh, Consultant Endocrinologist, G. D. Hospital & Diabetes Institute, Kolkata, West Bengal. Invitee Reviewer: Dr. Banshi Saboo, National President, RSSDI, Ahmedabad. Dr. Mangesh Tiwaskar, Consultant Physician & Diabetologist, Mumbai, Hon. General Secretary, API. Reviewer: Dr. R. Rajasekar, MD, FICP, FACP (USA), FRCP (Glasgow), FRCP (Ireland), Consultant Physician & Diabetologist Heart & Diabetes Therapy Centre, Kumbakonam, Tamil Nadu. -
Travel Bubble Flights Q. to Which Destinations Does Vistara Operate
FAQs - Travel Bubble Flights Q. To which destinations does Vistara operate on travel bubble flights from India? A. To know about the destinations we operate to, please refer to the Flight Schedule page on our website or through the GDS platform. Q. Can I book my ticket for onward travel from the point of destination? A. Vistara is offering only point to point travel. Q. How and where can I book my ticket for traveling from India on the travel bubble flights? A. New tickets can be booked via our website www.airvistara.com, through the travel agent or by calling our Customer Service Center on +91 9289228888. Q. I already have a Vistara ticket for the sector I wish to travel on. Can I use the same? A. For passengers with valid Vistara tickets (i.e ticket number starting with 228) for the sector of travel, an additional charge would be applicable. Please contact Vistara ticketing offices or the Customer Service Center +91 9289228888 for further details. Q. I am already holding a Visa for the destination country. Am I eligible to travel? A. For Vistara operated flights to Dubai from India, please note the following eligibility guidelines as on date: Only the following categories of passengers will be allowed entry to Dubai: • Holders of all types of visas i.e. Employment visa, Short/Long stay visa, visit visa, newly issued residency visa are permitted to travel to Dubai whether vaccinated or not vaccinated & do not require GDRFA or ICA Approval • Valid UAE resident visa holder • An exemption is also extended to following categories of passengers from the requirement of mandatory PCR test or GDRFA pre-approval prior traveling to Dubai, from all destinations: 1) The inbound passengers escorting a 1st degree UAE nationals’ relative. -
Highlights India Situation Covid-19
77 July 21, 2021 HIGHLIGHTS WHO Situation Update • MoHFW reviews preparations under “India COVID-19 Emergency Response India and Health Systems Preparedness Package: Phase II” with States/UTs (LINK) 31,174,322 Confirmed Cases • Union Minister of Tribal Affairs launches nationwide campaign ‘COVID Teeka Sang Surakshit Van, Dhan aur Uddyam’ aimed to clear misconceptions 414,482 Total Deaths regarding COVID vaccine amongst tribal population (LINK) South East Asia Region • Prime Minister interacts with Chief Minister of 6 States to discuss COVID-19 situation (LINK) 36,938,862 Confirmed Cases • B.1.617.2, known as the Delta variant, is around 40-60 percent more 531,186 Total Deaths transmissible than Alpha Variant; shares Co- Chair, INSACOG (LINK) World • IIT Ropar has developed a first-of-its-kind ‘oxygen rationing device’ – AMLEX 190,671,330 Confirmed Cases to increase the life of medical oxygen cylinders (LINK) 4,098,758 Deaths INDIA SITUATION • In India, highest number of cases in a day were 4,14,188; reported on 7 May 2021. Since then there has been a continuous decline in daily cases, now India reports 28 daily cases per million population. Variant of Concern (VOC) reported in India* * Data source: NCDC/IDSP as of 14th July 2021 https://ihip.nhp.gov.in/idsp/#!/ COVID-19: STATUS ACROSS STATES • In the past week (15-20 July), as compared to previous week (8-13 July), all states/UTs have shown a decrease in cases except A & N Islands, Nagaland, Mizoram, Manipur, Sikkim, Kerala, Arunachal Pradesh and Telangana. 77 July 21, 2021 • In Andhra Pradesh, night curfew implemented from 10:00 pm to 6:00 am has been extended till further notice.